CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-17 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award · Stock Option (right to buy) | +12,833 | 12,833 | ||
| 2018-01-17 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award · Stock Option (right to buy) | +9,994 | 9,994 | ||
| 2018-01-17 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award · Stock Option (right to buy) | +6,719 | 6,719 | ||
| 2018-01-17 | Lynch Thomas G Director | Grant or award · Stock Option (right to buy) | +3,850 | 3,850 | ||
| 2018-01-17 | File Justin J. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +12,833 | 12,833 | ||
| 2018-01-17 | File Justin J. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +10,266 | 10,266 | ||
| 2018-01-17 | Culwell Kelly Chief Medical Officer | Grant or award · Stock Option (right to buy) | +7,699 | 7,699 | ||
| 2018-01-17 | Barrans Russell Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +3,850 | 3,850 | ||
| 2018-01-17 | Barrans Russell Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +1,283 | 1,283 | ||
| 2017-06-22 | Knudson Susan A. Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2017-06-22 | Feldman Maria VP, Clinical Research | Grant or award · Employee Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2017-06-20 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +12,450 | 12,450 | ||
| 2017-06-20 | DEMSKI MARTHA J Director | Grant or award · Stock Option (Right to Buy) | +12,450 | 12,450 | ||
| 2017-06-20 | Nugent Jeffrey M Director | Grant or award · Stock Option (Right to Buy) | +12,450 | 12,450 | ||
| 2017-06-20 | Gorbachev Maxim Director | Grant or award · Stock Option (Right to Buy) | +12,450 | 12,450 | ||
| 2017-05-11 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +63,500 | 63,500 | ||
| 2017-05-11 | DEMSKI MARTHA J Director | Grant or award · Stock Option (Right to Buy) | +63,500 | 63,500 | ||
| 2017-05-11 | Nugent Jeffrey M Director | Grant or award · Stock Option (Right to Buy) | +63,500 | 63,500 | ||
| 2017-03-02 | Feldman Maria VP Clinical Research & Operati | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2017-03-02 | Knudson Susan A. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 13 of 20 · 383 trades